Literature DB >> 24697566

Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.

Young Ho Lee1, Sang-Cheol Bae, Gwan Gyu Song.   

Abstract

INTRODUCTION: The purpose of this study was to examine whether a Proline (Pro)-to-Alanine (Ala) exchange at codon 12 (Pro12Ala) polymorphism of the peroxisome proliferator-activated receptor-gamma (PPARγ) is associated with susceptibility to nonalcoholic fatty liver disease (NAFLD), rheumatoid arthritis (RA), and psoriatic arthritis (PsA).
METHODS: A meta-analysis was conducted on the association between the PPARγ Pro12Ala polymorphism and NAFLD, RA, and PsA.
RESULTS: Nine studies, including five on NAFLD, two on RA, and two on PsA, were available for the meta-analysis consisting of 8082 cases and 3790 controls. The meta-analysis revealed no association between the Ala allele of the PPARγ Pro12Ala polymorphism and NAFLD (odds ratios [OR]=0.936, 95% confidence interval [CI]=0.672-1.302, p=0.693). However, stratification by ethnicity indicated an association between the Ala allele and NAFLD in East Asians (OR=0.700, 95% CI=0.496-0.987, p=0.042), but not in Europeans (OR=1.128, 95% CI=0.863-1.475, p=0.378). Analysis using the dominant model showed the same Ala allele pattern in East Asians and Europeans (OR=0.688, 95% CI=0.484-0.978, p=0.037; OR=1.051, 95% CI=0.782-1.413, p=0.742), demonstrating a significant association between the Ala allele and NAFLD in East Asians. The meta-analysis revealed no association between the Ala allele and RA in East Asians (OR=0.467, 95% CI=0.188-1.161, p=0.101), and no association was found between the Ala allele and PsA in Europeans (OR=0.869, 95% CI=0.465-1.627, p=0.662).
CONCLUSIONS: Our meta-analysis demonstrates that the PPARγ Pro12Ala polymorphism is associated with susceptibility to NAFLD in East Asians, but not in European populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24697566      PMCID: PMC4010165          DOI: 10.1089/gtmb.2013.0503

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  34 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Genome scan meta-analysis of rheumatoid arthritis.

Authors:  S J Choi; Y H Rho; J D Ji; G G Song; Y H Lee
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

3.  Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility.

Authors:  John Bowes; Pauline Ho; Edward Flynn; Salma Salah; Neil McHugh; Oliver FitzGerald; Jonathan Packham; Ann W Morgan; Philip S Helliwell; Ian N Bruce; Anne Barton
Journal:  Ann Rheum Dis       Date:  2011-07-28       Impact factor: 19.103

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.

Authors:  Chuang-Yu Cao; Yu-Yuan Li; Yong-Jian Zhou; Yu-Qiang Nie; Yu-Jui Yvonne Wan
Journal:  Tohoku J Exp Med       Date:  2012-08       Impact factor: 1.848

6.  Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.

Authors:  Johannes-W Rey; Andrea Noetel; Aline Hardt; Ali Canbay; Hakan Alakus; Axel Zur Hausen; Hans-Peter Dienes; Uta Drebber; Margarete Odenthal
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

7.  Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.

Authors:  Surya Prakash Bhatt; Priyanka Nigam; Anoop Misra; Randeep Guleria; Kalpana Luthra; Ravindra Mohan Pandey; M A Qadar Pasha
Journal:  Gene       Date:  2012-09-29       Impact factor: 3.688

8.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

Review 9.  [PPARgamma and metabolic syndrome].

Authors:  Yasuo Terauchi
Journal:  Rinsho Byori       Date:  2007-05

10.  Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress.

Authors:  Weijia Luo; Jin Cao; Jie Li; Weimin He
Journal:  Exp Gerontol       Date:  2007-11-21       Impact factor: 4.032

View more
  7 in total

1.  Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPARγ2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease.

Authors:  Somayye Taghvaei; Leila Saremi
Journal:  PPAR Res       Date:  2022-05-02       Impact factor: 4.385

Review 2.  Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.

Authors:  Xiao-Lin Li; Jian-Qing Sui; Lin-Lin Lu; Nan-Nan Zhang; Xin Xu; Quan-Yong Dong; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2016-03-10       Impact factor: 3.876

Review 3.  Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease.

Authors:  Nan Wang; Rui Kong; Hui Luo; Xiaorong Xu; Jie Lu
Journal:  PPAR Res       Date:  2017-12-05       Impact factor: 4.964

4.  Fatty liver in Pakistani cohort with rheumatoid arthritis.

Authors:  Abrar Ahmed Wagan; Abdul Qadir Bhutoo; Daim Khan; Abdul Raheem
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

5.  Knowledge-Based Neuroendocrine Immunomodulation (NIM) Molecular Network Construction and Its Application.

Authors:  Tongxing Wang; Lu Han; Xiaorui Zhang; Rongrong Wu; Xiaorui Cheng; Wenxia Zhou; Yongxiang Zhang
Journal:  Molecules       Date:  2018-05-30       Impact factor: 4.411

6.  The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus.

Authors:  Leila Saremi; Shirin Lotfipanah; Masumeh Mohammadi; Hassan Hosseinzadeh; Mina Fathi-Kazerooni; Behrooz Johari; Zohreh Saltanatpour
Journal:  Cell Mol Biol Lett       Date:  2019-03-15       Impact factor: 5.787

7.  Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Xiao-Feng Li; Ying-Yin Sun; Jing Bao; Xin Chen; Yu-Huan Li; Yang Yang; Lei Zhang; Cheng Huang; Bao-Ming Wu; Xiao-Ming Meng; Jun Li
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.